Abstract
The Use of Prognostic Markers to Predict Disease Progression and Clinical Outcome in Monoclonal Gammopathy of Undetermined Significance, Smouldering Multiple Myeloma and Multiple Myeloma.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Undergraduate Journal of Health Sciences
Paper Title
Journal
Date
